MCO-020

N/A

Report date: 2026/01/26 11:06:27

Base Information

Drug NameMCO-020
Drug Alias NameMCO-020MCO020
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionEye protein replacements
TargetsEye proteins
Therapy Area/IndicationsGeographic Atrophy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNanoscope Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesNanoscope Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsGeographic Atrophy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A